title: Prevalence and predictors of regularly scheduled prescription medications of newly admitted nursing home residents.
abstract: OBJECTIVE
  The purpose of this study was to identify the prevalence and predictors of commonly prescribed regularly scheduled medications.
  
  
  METHODS
  Data were collected on the first day following nursing home admission in this non-experimental study.
  
  
  METHODS
  A stratified, proportional probability sample of eight nursing homes in a large Mid-South city participated in this study.
  
  
  METHODS
  A consecutive sample of 574 new and readmitted nursing home residents who did not refuse participation.
  
  
  METHODS
  None.
  
  
  METHODS
  Data were collected on regularly scheduled prescription medications and resident and nursing home characteristics.
  
  
  RESULTS
  Residents without a diagnosis of dementia were more likely to receive cardiovascular medications (Odds Ratio = 2.34; 95% CI = 1.56-3.49), and white residents were more likely to receive cardiovascular medications (Odds Ratio = 1.74; 95% CI = 1.19-2.53) or central nervous system medications (Odds Ratio = 1.72; 95% CI = 1.18-2.51). Older residents were less likely to receive central nervous system medications (Odds Ratio = 0.97 per year; 95% CI = 0.96-0.99), and females were more likely to receive cardiovascular medications (Odds Ratio = 1.89; 95% CI = 1.30-2.75).
  
  
  CONCLUSIONS
  Resident characteristics were the most important predictors for cardiovascular and central nervous system medication prescriptions of new and readmitted nursing home residents.
authors.affiliation: College of Nursing, University of Tennessee, Memphis 38163.
authors.forename: E A
authors.initials: EA
authors.lastname: Renner
authors.forename: V F
authors.initials: VF
authors.lastname: Engle
authors.forename: M J
authors.initials: MJ
authors.lastname: Graney
mesh_terms: D000328:Adult; D001741:Black or African American / Q000706:statistics & numerical data; D000368:Aged; D000369:Aged, 80 and over; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology; D002491:Central Nervous System Agents / Q000627:therapeutic use*; D015897:Comorbidity; D003704:Dementia / Q000188:drug therapy / Q000453:epidemiology; D011307:Drug Prescriptions / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009735:Nursing Homes; D010343:Patient Admission; D011237:Predictive Value of Tests; D015995:Prevalence; D012494:Sampling Studies; D012737:Sex Factors; D015144:Southeastern United States / Q000453:epidemiology; D015206:Southwestern United States / Q000453:epidemiology; D044465:White People / Q000706:statistics & numerical data
chemical_list: D002317:Cardiovascular Agents; D002491:Central Nervous System Agents